http://orcid.org/0000-0002-3309-3181
Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Phil McEwan, Piotr Ponikowski, Tinevimbo Shiri, Giuseppe M. C. Rosano, Andrew J. S. Coats, Fabio Dorigotti, Antonio Ramirez de Arellano & Ewa A. Jankowska. (2023) Clinical and economic impact of ferric carboxymaltose treatment for iron deficiency in patients stabilized following acute heart failure: a multinational study. Journal of Medical Economics 26:1, pages 51-60.
Read now
Read now
Syed Numan & Karolina Kaluza. (2020) Systematic review of guidelines for the diagnosis and treatment of iron deficiency anemia using intravenous iron across multiple indications. Current Medical Research and Opinion 36:11, pages 1769-1782.
Read now
Read now
Articles from other publishers (6)
Aziz Rezapour, Aghdas Souresrafil, Monireh Shamsaei, Mohammad Barzegar, Mahsa Tashakori-Miyanroudi & Ensiyeh Ketabchi. (2023) Economic evaluation of ferric carboxymaltose compared with placebo in iron-deficient patients with heart failure: a systematic review. International Journal of Clinical Pharmacy 45:3, pages 566-576.
Crossref
Crossref
Phil McEwan, Cale Harrison, Rhona Binnie, Ruth D. Lewis, Alain Cohen‐Solal, Lars H. Lund, Marcus Ohlsson, Stephan von Haehling, Josep Comin‐Colet, Domingo A. Pascual‐Figal, Sandra Wächter, Fabio Dorigotti, Antonio Ramirez de Arellano, Piotr Ponikowski & Ewa A. Jankowska. (2023) Impact of ferric carboxymaltose for iron deficiency at discharge after heart failure hospitalization: a European multinational economic evaluation. European Journal of Heart Failure 25:3, pages 389-398.
Crossref
Crossref
Elisabeth Brock, Giorgio Moschovitis, Micha T. Maeder & Otmar Pfister. (2022) Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF) and Iron Deficiency in Switzerland. PharmacoEconomics - Open 6:5, pages 735-743.
Crossref
Crossref
Andrew B. Song, David J. Kuter & Hanny Al‐Samkari. (2020) Characterization of the rate, predictors, and thrombotic complications of thrombocytosis in iron deficiency anemia. American Journal of Hematology 95:10, pages 1180-1186.
Crossref
Crossref
Carla Rognoni & Simone Gerzeli. (2019) Ferric carboxymaltose for patients with heart failure and iron deficiency in Italy: cost–effectiveness and budget impact. Journal of Comparative Effectiveness Research 8:13, pages 1099-1110.
Crossref
Crossref
Oren Zusman, Osnat Itzhaki Ben Zadok & Anat Gafter-Gvili. (2019) Management of Iron Deficiency in Heart Failure. Acta Haematologica 142:1, pages 51-56.
Crossref
Crossref